この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2005/11/231 分で読めます
Investigational New Drugs: Export Requirements for Unapproved New Drug Products
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is amending its regulations on the exportation of investigational new drugs, including biological products. The final rule describes four different mechanisms for exporting an investigational new drug product. These provisions implement changes in FDA's export authority resulting from the FDA Export Reform and Enhancement Act of 1996 and also simplify the existing requirements for exports of investigational new drugs.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →